Nuvo Research Provides Pennsaid® Update
MISSISSAUGA, ON, April 12, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a
specialty pharmaceutical company dedicated to building a portfolio of
products for the topical treatment of pain and the development of its
immune modulating drug candidate WF10, today provided an update on U.S.
developments relating to Pennsaid, its topical non-steroidal
anti-inflammatory drug (NSAID) used to treat the signs and symptoms of
osteoarthritis (OA) of the knee.
Pennsaid U.S.
Pennsaid is sold in the U.S.
Swank Capital and Cushing® MLP Asset Management Announce Rebalancing of the Cushing® MLP High Income Index
DALLAS, April 5, 2012 /PRNewswire/ -- Swank Capital, LLC and Cushing® MLP Asset Management, LP announced today that the 30 members of the Cushing® MLP High Income Index will be rebalanced after the market close on April 13, 2012 as part of normal index operations.
diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
SOUTH SAN FRANCISCO, Calif., March 19, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on proprietary cardiovascular diagnostic products, today highlighted data from two recent studies evaluating the clinical utility of its PLAC® Test for Lp-PLA(2) Activity.
Commercial Payment Cards: The U.S. and Global Markets and Trends, 7th Edition
NEW YORK, March 7, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Commercial Payment Cards: The U.S. and Global Markets and Trends, 7th Edition
With job creation showing signs of accelerating at the beginning of 2012, there is a renewed sense that business expansion will once again breathe life into the U.S.
